Next-generation 'epigenetic' cancer pill shown to be safe in phase I trial
" CHR-3996 was tested in 39 patients with a range of advanced cancers."
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.